Back to Startups

Verdiva Bio

Bioscience & Disease Personal Health Healthcare Systems
Bioscience & Disease Personal Health Healthcare Systems Show less
Bioscience & Disease Personal Health +1
Bioscience & Disease Personal Health Healthcare Systems Show less
Website LinkedIn London, United Kingdom
About Verdiva Bio

Verdiva Bio is committed to developing next-generation therapies to help people living with obesity, cardiometabolic disorders, and related complications.

Business Information
Target Customers
healthcare providers patients with obesity research institutions
Industry Categories
Bioscience & Disease Personal Health Healthcare Systems
Business Model
Revenue Model Pharmaceutical sales
Pricing Strategy Value-based pricing
Sales Channels direct sales, partnerships with healthcare providers
Funding Timeline
Round Date Amount Investors
Series A Jan 09, 2025 $327.0M Unknown
Founders

No founder information available.

Investors

No investor information available.

Recent Mentions
BIA_UK
BioIndustry Association (BIA) @BIA_UK
May 09, 2025

We’ve just published our UK #biotech financing report, offering a comprehensive overview of sector activity from January to March 2025. ➡️ https://t.co/4kxLgR4qLi One of the standout financings came from Verdiva Bio, which closed a £327 million Series A round on 9 January. This https://t.co/8sRHRNBHVp

View on Twitter
Similar Startups
Vima Therapeutics
87% match

Vima Therapeutics is a biotechnology startup focused on developing innovative therapies to address u...
Vivodyne
85% match

Vivodyne is a biotechnology startup leveraging artificial intelligence to innovate in the healthcare...
Therini Bio
85% match

Therini Bio is a biotechnology company focused on developing innovative therapeutics for neurodegene...
Longbio
85% match

Longbio Pharma is a biotech startup focused on developing innovative therapies for autoimmune and ra...